Developer docs
API playgroundTry for free, no card

Search company profiles

Life Whisperer

Full company profile

uuid000282w

Namestring
Life Whisperer
Legal namestring
ASTEC CO., Ltd.
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Life Whisperer is a private AI healthcare company founded in 2016 that develops deep-learning computer vision software for IVF clinics and fertility centers. Its products analyze static microscope images of embryos, oocytes, and endometrial tissue to predict viability, euploidy, blastocyst formation potential, and implantation likelihood, without invasive procedures or additional hardware. Originally built as the fertility arm of Australian AI healthcare firm Presagen, Life Whisperer was acquired in November 2025 by Astec Co., Ltd., a Japanese manufacturer of IVF and life science equipment, which now operates the company globally with offices in Adelaide, San Francisco, London, and Tokyo.

The product suite comprises four offerings: Life Whisperer Viability (LWV) for embryo viability assessment, Life Whisperer Genetics (LWG) for non-invasive euploidy prediction, Life Whisperer Oocytes (LWO) for oocyte competence evaluation prior to ICSI, and Life Whisperer Endometrial Receptivity (LWER), which is still in development. The AI is trained on diverse global clinical data via a proprietary federated learning platform with Untrainable Data Cleansing (UDC) technology, enabling privacy-preserving training across distributed clinic data silos. Disclosed performance metrics include 25% higher accuracy than manual grading at identifying viable embryos, 30.8% higher accuracy than traditional embryologist morphology assessment, a 12% reduction in time to pregnancy, and 82% of cohorts having the AI top-ranked embryo confirmed euploid. Validation appears in Human Reproduction, Nature Scientific Reports, and Reproductive BioMedicine Online.

Life Whisperer monetizes through a pay-per-use web-based SaaS model with no setup, hardware, maintenance, or subscription fees, supplemented by royalty payments to clinics that contribute training data. Distribution combines direct enterprise sales, the FUJIFILM Irvine Scientific global channel (sole worldwide distributor since August 2021), and regional partners such as GoHealthe in India, Bangladesh, and Sri Lanka. Customer coverage spans large multi-clinic chains including Indira IVF (100+ clinics in India), Morula IVF (Indonesia), Bloom IVF Group, Ovation Fertility, IVF Life Group (Spain, UK, Germany), and numerous independent clinics across the US, UK, Europe, Japan, and Australia, with regulatory clearances including CE Mark, HIPAA, GDPR, and ISO-13485.

Short descriptiontext

Life Whisperer, founded in 2016 and acquired by Japan's Astec in November 2025, builds AI computer-vision software for IVF clinics that non-invasively scores embryo viability, euploidy, and oocyte quality from standard microscope images on a pay-per-use web platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI fertility assessment, IVF embryo analysis, AI embryo viability, computer vision ART, non-invasive embryo selection
Industry2 codes
1Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation)
CodeHLALAHAAPrimaryYes
2Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling)
CodeHLALAHAKPrimaryNo
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Prepackaged Software7372
Product category
AI-powered IVF / Fertility Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Pay-per-use AI assessment fees
TypeUsage Based
Description

Life Whisperer charges IVF clinics on a pay-per-use basis for AI embryo assessment services accessed through the web platform. No setup, maintenance, or subscription fees required.

lifewhisperer.com
2Royalties from clinic data contribution
TypeLicensing Royalties
Description

Collaborating clinics that contribute data to AI training receive royalties, creating a data network effect and incentivizing global data collection.

lifewhisperer.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Pay-per-use model with no setup or subscription fees
ModelUsage-basedBilling cadencePay-as-you-go
Notes

No capital outlay required. No expensive equipment, ongoing maintenance, or subscription fees. Pay-per-use fee for AI embryo assessment services.

lifewhisperer.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1Life Whisperer Viability (LWV)
Description

AI-based embryo viability assessment tool that evaluates the likelihood of clinical pregnancy from a single static embryo image.

lifewhisperer.com
+3 more records
Core offering1 text field

Life Whisperer provides a suite of cloud-based AI applications that analyze static microscope images of embryos, oocytes, and endometrial tissue to predict viability, genetic normalcy, and implantation potential. The products are delivered as web-based, drag-and-drop applications that IVF clinics access on a pay-per-use basis without additional hardware. The AI was developed and is operated under parent company Astec CO., Ltd. (Japan).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 25% more accurate than manual grading at identifying viable embryos
+6 more records
Product overview1 text field

Life Whisperer is an AI-powered suite of web-based products for IVF treatment. The portfolio includes four main offerings: Life Whisperer Viability (LWV) for embryo viability assessment, Life Whisperer Genetics (LWG) for embryo euploidy assessment, Life Whisperer Oocytes (LWO) for oocyte competence evaluation, and Life Whisperer Endometrial Receptivity (LWER) for endometrial receptivity analysis (in development). All products are non-invasive, cloud-based web applications that use deep learning computer vision to analyze standard microscope or ultrasound images and provide instant AI-generated scores to assist embryologists in embryo and oocyte selection decisions. Products operate on a pay-per-use model without hardware requirements and are delivered by parent company Astec (Japan).

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-01-22
Description

Indonesia's largest IVF clinic group. First clinic in Indonesia to use Life Whisperer AI. Reported 5% increase in success rates after implementing AI.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-10-23
Description

India's largest and most advanced IVF clinic group. Rolling out Life Whisperer AI across their 100+ clinics in India to improve pregnancy outcomes for all patients.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-10-04
Description

One of the oldest IVF chains in India, using Life Whisperer AI across their clinics to help patients get pregnant sooner and for lower cost.

Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-08-10
Description

FUJIFILM Irvine Scientific became the sole worldwide distributor of Life Whisperer in August 2021. As a world leader in cell culture media and assisted reproductive technologies, they distribute Life Whisperer to IVF clinics globally.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-05-31
Description

Leading IVF clinic group across Spain, UK, and Germany. First clinic group in Europe to use AI to non-invasively assess genetic integrity of embryos.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2020-06-17
Description

Partnership with GoHealthe for distribution of Life Whisperer in India, Bangladesh, and Sri Lanka markets.

Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2020-02-24
Description

Exclusive global partnership with Fertility Road, a leading global fertility media brand, to reach IVF professionals and patients worldwide.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-04-24
Description

First US IVF provider to evaluate Life Whisperer AI. Long-standing research collaboration partner in multiple clinical studies on embryo viability and genetics AI. Collaborated on combined use of viability and genetics AI algorithms.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-07-04
Description

Initial partnership with Monash IVF Group (ASX: MVF) and its subsidiary Repromed to apply AI technology to improve fertility outcomes. One of the first major clinic partnerships.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Life Whisperer is provided and operated by Astec, a leading manufacturer of IVF and life science equipment based in Japan. Astec acquired Life Whisperer/Presagen's fertility business, integrating cutting-edge AI technology with their long-standing expertise in reproductive equipment.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Life Whisperer is the fertility arm of AI healthcare company Presagen. Presagen developed the AI technology, federated learning platform, and data cleansing algorithms. Life Whisperer was part of Presagen until acquisition by Astec.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Vitrolife Group markets the iDAScore AI on its EmbryoScope time-lapse platform, the most widely installed AI embryo assessment system in IVF clinics worldwide. It directly competes with Life Whisperer in non-invasive embryo selection, just delivered through a bundled camera+software model.

TypeEmerging player
Description

AIVF provides an AI decision-support platform for IVF clinics that combines embryo scoring, cycle planning, and lab workflow optimization. It overlaps with Life Whisperer in IVF AI but offers broader clinic-management scope as an emerging alternative.

TypeEmerging player
Description

Univfy provides AI-based fertility success prediction to help patients and clinics decide on IVF treatment plans. It is adjacent to Life Whisperer in fertility AI but focuses on treatment-decision support rather than embryo/oocyte image analysis.

TypeDirect peer
Description

Fairtility offers CHLOE, an AI platform for embryo assessment that integrates morphology and additional clinical data to prioritize embryos. It is a direct functional competitor to Life Whisperer in IVF AI ranking and selection.

TypeBroad incumbent
Description

Hamilton Thorne is an established IVF and reproductive medicine equipment vendor offering lasers, time-lapse, and lab automation. As an incumbent ART equipment provider, it competes indirectly via broader IVF lab solutions that integrate with or rival Life Whisperer's standalone AI.

TypeBroad incumbent
Description

CooperSurgical is a large, diversified fertility and women's health company offering IVF consumables, devices, and services globally. It competes with Life Whisperer across the IVF value chain and is a likely strategic acquirer or partner for AI-driven fertility analytics.

TypeRegional player
Description

Genea Biomedx, the technology arm of Genea (Australia), develops IVF lab devices and software including Geri time-lapse incubators. It is a regional competitor in the Australian/Asia-Pacific IVF tech market, overlapping Life Whisperer's home geography.

TypeOthers
Description

Ovation Fertility is a US IVF clinic network and early Life Whisperer technology partner. As a clinic operator (rather than software vendor), it is ecosystem-relevant—collaborating on validation studies and adoption, but not a direct product competitor.

TypeBroad incumbent
Description

FUJIFILM Irvine Scientific is the world's leading ART media supplier and Life Whisperer's sole worldwide distributor. Beyond distribution, it is also a developer of ART products and overlaps Life Whisperer's IVF footprint through its media, devices, and now AI offerings.

TypeDirect peer
Description

ImVitro develops AI-based image analysis for embryo quality assessment in IVF, focused on clinical workflows and embryo ploidy prediction. It competes head-to-head with Life Whisperer's Viability and Genetics offerings for IVF clinic accounts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Life Whisperer

AI-powered IVF / Fertility Softwarelifewhisperer.com

Life Whisperer, founded in 2016 and acquired by Japan's Astec in November 2025, builds AI computer-vision software for IVF clinics that non-invasively scores embryo viability, euploidy, and oocyte quality from standard microscope images on a pay-per-use web platform.

What Life Whisperer does

Life Whisperer is a private AI healthcare company founded in 2016 that develops deep-learning computer vision software for IVF clinics and fertility centers. Its products analyze static microscope images of embryos, oocytes, and endometrial tissue to predict viability, euploidy, blastocyst formation potential, and implantation likelihood, without invasive procedures or additional hardware. Originally built as the fertility arm of Australian AI healthcare firm Presagen, Life Whisperer was acquired in November 2025 by Astec Co., Ltd., a Japanese manufacturer of IVF and life science equipment, which now operates the company globally with offices in Adelaide, San Francisco, London, and Tokyo.

The product suite comprises four offerings: Life Whisperer Viability (LWV) for embryo viability assessment, Life Whisperer Genetics (LWG) for non-invasive euploidy prediction, Life Whisperer Oocytes (LWO) for oocyte competence evaluation prior to ICSI, and Life Whisperer Endometrial Receptivity (LWER), which is still in development. The AI is trained on diverse global clinical data via a proprietary federated learning platform with Untrainable Data Cleansing (UDC) technology, enabling privacy-preserving training across distributed clinic data silos. Disclosed performance metrics include 25% higher accuracy than manual grading at identifying viable embryos, 30.8% higher accuracy than traditional embryologist morphology assessment, a 12% reduction in time to pregnancy, and 82% of cohorts having the AI top-ranked embryo confirmed euploid. Validation appears in Human Reproduction, Nature Scientific Reports, and Reproductive BioMedicine Online.

Life Whisperer monetizes through a pay-per-use web-based SaaS model with no setup, hardware, maintenance, or subscription fees, supplemented by royalty payments to clinics that contribute training data. Distribution combines direct enterprise sales, the FUJIFILM Irvine Scientific global channel (sole worldwide distributor since August 2021), and regional partners such as GoHealthe in India, Bangladesh, and Sri Lanka. Customer coverage spans large multi-clinic chains including Indira IVF (100+ clinics in India), Morula IVF (Indonesia), Bloom IVF Group, Ovation Fertility, IVF Life Group (Spain, UK, Germany), and numerous independent clinics across the US, UK, Europe, Japan, and Australia, with regulatory clearances including CE Mark, HIPAA, GDPR, and ISO-13485.

Life Whisperer firmographics

Firmographics
Name
Life Whisperer
Legal name
ASTEC CO., Ltd.
Website
https://lifewhisperer.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Life Whisperer, founded in 2016 and acquired by Japan's Astec in November 2025, builds AI computer-vision software for IVF clinics that non-invasively scores embryo viability, euploidy, and oocyte quality from standard microscope images on a pay-per-use web platform.
Ownership category
akta.pro rank

Life Whisperer industry classification

Industry
Product category
AI-powered IVF / Fertility Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372)
akta.pro primary industry
Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA)
akta.pro secondary industry
Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling) (HLALAHAK)

Keywords

  • AI fertility assessment
  • IVF embryo analysis
  • AI embryo viability
  • Computer vision ART
  • Non-invasive embryo selection

Where Life Whisperer is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Life Whisperer business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Pay-per-use AI assessment fees: Life Whisperer charges IVF clinics on a pay-per-use basis for AI embryo assessment services accessed through the web platform. No setup, maintenance, or subscription fees required.
  2. Royalties from clinic data contribution: Collaborating clinics that contribute data to AI training receive royalties, creating a data network effect and incentivizing global data collection.

Pricing tiers

ModelBillingPrice
Usage-basedPay-as-you-goPay-per-use model with no setup or subscription fees

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Life Whisperer product offering

Product offering

Core offering

Life Whisperer provides a suite of cloud-based AI applications that analyze static microscope images of embryos, oocytes, and endometrial tissue to predict viability, genetic normalcy, and implantation potential. The products are delivered as web-based, drag-and-drop applications that IVF clinics access on a pay-per-use basis without additional hardware. The AI was developed and is operated under parent company Astec CO., Ltd. (Japan).

Product overview

Life Whisperer is an AI-powered suite of web-based products for IVF treatment. The portfolio includes four main offerings: Life Whisperer Viability (LWV) for embryo viability assessment, Life Whisperer Genetics (LWG) for embryo euploidy assessment, Life Whisperer Oocytes (LWO) for oocyte competence evaluation, and Life Whisperer Endometrial Receptivity (LWER) for endometrial receptivity analysis (in development). All products are non-invasive, cloud-based web applications that use deep learning computer vision to analyze standard microscope or ultrasound images and provide instant AI-generated scores to assist embryologists in embryo and oocyte selection decisions. Products operate on a pay-per-use model without hardware requirements and are delivered by parent company Astec (Japan).

Differentiator

Problem solved

Functional benefit

Brands

  • Life Whisperer Viability (LWV): AI-based embryo viability assessment tool that evaluates the likelihood of clinical pregnancy from a single static embryo image.
  • Life Whisperer Genetics (LWG)
  • Life Whisperer Oocytes (LWO)
  • Life Whisperer Endometrial Receptivity (LWER)

Quantifiable outcome

  • 25% more accurate than manual grading at identifying viable embryos
  • +6 more outcomes

Companies that use Life Whisperer

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles2 records

Life Whisperer technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

Life Whisperer partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and flagship.

  • Morula IVFcoreTechnology or Integration · 22 January 2024Indonesia's largest IVF clinic group. First clinic in Indonesia to use Life Whisperer AI. Reported 5% increase in success rates after implementing AI.
  • Indira IVFcoreTechnology or Integration · 23 October 2022India's largest and most advanced IVF clinic group. Rolling out Life Whisperer AI across their 100+ clinics in India to improve pregnancy outcomes for all patients.
  • Bloom IVF GroupcoreTechnology or Integration · 4 October 2022One of the oldest IVF chains in India, using Life Whisperer AI across their clinics to help patients get pregnant sooner and for lower cost.
  • FUJIFILM Irvine ScientificflagshipChannel Partner/ Reseller/ Distributor · 10 August 2021FUJIFILM Irvine Scientific became the sole worldwide distributor of Life Whisperer in August 2021. As a world leader in cell culture media and assisted reproductive technologies, they distribute Life Whisperer to IVF clinics globally.
  • IVF Life GroupcoreTechnology or Integration · 31 May 2021Leading IVF clinic group across Spain, UK, and Germany. First clinic group in Europe to use AI to non-invasively assess genetic integrity of embryos.
  • GoHealthecoreChannel Partner/ Reseller/ Distributor · 17 June 2020Partnership with GoHealthe for distribution of Life Whisperer in India, Bangladesh, and Sri Lanka markets.
  • Fertility RoadcoreGTM or Marketing Partner · 24 February 2020Exclusive global partnership with Fertility Road, a leading global fertility media brand, to reach IVF professionals and patients worldwide.
  • Ovation FertilitycoreStrategic or Co-development Partner · 24 April 2018First US IVF provider to evaluate Life Whisperer AI. Long-standing research collaboration partner in multiple clinical studies on embryo viability and genetics AI. Collaborated on combined use of viability and genetics AI algorithms.
  • Monash IVF GroupcoreStrategic or Co-development Partner · 4 July 2017Initial partnership with Monash IVF Group (ASX: MVF) and its subsidiary Repromed to apply AI technology to improve fertility outcomes. One of the first major clinic partnerships.
  • Astec (ASTEC CO., Ltd.)flagshipStrategic or Co-development PartnerLife Whisperer is provided and operated by Astec, a leading manufacturer of IVF and life science equipment based in Japan. Astec acquired Life Whisperer/Presagen's fertility business, integrating cutting-edge AI technology with their long-standing expertise in reproductive equipment.
  • PresagenflagshipStrategic or Co-development PartnerLife Whisperer is the fertility arm of AI healthcare company Presagen. Presagen developed the AI technology, federated learning platform, and data cleansing algorithms. Life Whisperer was part of Presagen until acquisition by Astec.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Life Whisperer competitors and assessment

Company assessment

Direct peers

  • Vitrolife (Vitrolife Group): Vitrolife Group markets the iDAScore AI on its EmbryoScope time-lapse platform, the most widely installed AI embryo assessment system in IVF clinics worldwide. It directly competes with Life Whisperer in non-invasive embryo selection, just delivered through a bundled camera+software model.
  • Fairtility: Fairtility offers CHLOE, an AI platform for embryo assessment that integrates morphology and additional clinical data to prioritize embryos. It is a direct functional competitor to Life Whisperer in IVF AI ranking and selection.
  • ImVitro: ImVitro develops AI-based image analysis for embryo quality assessment in IVF, focused on clinical workflows and embryo ploidy prediction. It competes head-to-head with Life Whisperer's Viability and Genetics offerings for IVF clinic accounts.

Emerging players

  • AIVF: AIVF provides an AI decision-support platform for IVF clinics that combines embryo scoring, cycle planning, and lab workflow optimization. It overlaps with Life Whisperer in IVF AI but offers broader clinic-management scope as an emerging alternative.
  • Univfy: Univfy provides AI-based fertility success prediction to help patients and clinics decide on IVF treatment plans. It is adjacent to Life Whisperer in fertility AI but focuses on treatment-decision support rather than embryo/oocyte image analysis.

Broad incumbents

  • Hamilton Thorne: Hamilton Thorne is an established IVF and reproductive medicine equipment vendor offering lasers, time-lapse, and lab automation. As an incumbent ART equipment provider, it competes indirectly via broader IVF lab solutions that integrate with or rival Life Whisperer's standalone AI.
  • CooperSurgical (CooperCompanies): CooperSurgical is a large, diversified fertility and women's health company offering IVF consumables, devices, and services globally. It competes with Life Whisperer across the IVF value chain and is a likely strategic acquirer or partner for AI-driven fertility analytics.
  • FUJIFILM Irvine Scientific: FUJIFILM Irvine Scientific is the world's leading ART media supplier and Life Whisperer's sole worldwide distributor. Beyond distribution, it is also a developer of ART products and overlaps Life Whisperer's IVF footprint through its media, devices, and now AI offerings.

Regional players

  • Genea Biomedx: Genea Biomedx, the technology arm of Genea (Australia), develops IVF lab devices and software including Geri time-lapse incubators. It is a regional competitor in the Australian/Asia-Pacific IVF tech market, overlapping Life Whisperer's home geography.

Others

  • Ovation Fertility: Ovation Fertility is a US IVF clinic network and early Life Whisperer technology partner. As a clinic operator (rather than software vendor), it is ecosystem-relevant—collaborating on validation studies and adoption, but not a direct product competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Life Whisperer social profiles

Digital presence

Life Whisperer compliance and trust

Trust signal

Compliance4 records

Life Whisperer financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Life Whisperer leadership team

Management profile

Number of profiles

Profiles4 records

Life Whisperer funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Life Whisperer M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Life Whisperer

What does Life Whisperer do?

Life Whisperer provides a suite of cloud-based AI applications that analyze static microscope images of embryos, oocytes, and endometrial tissue to predict viability, genetic normalcy, and implantation potential. The products are delivered as web-based, drag-and-drop applications that IVF clinics access on a pay-per-use basis without additional hardware. The AI was developed and is operated under parent company Astec CO., Ltd. (Japan).

Is Life Whisperer a public or private company?

Life Whisperer is a private company. It is classified as corporate owned and is currently operating.

When was Life Whisperer founded?

Life Whisperer was founded in 2016. It employs 11 to 50 people.

Where is Life Whisperer based?

Life Whisperer is headquartered in San Francisco, United States, in the North America region.

How does Life Whisperer make money?

Two revenue lines are on record. Pay-per-use AI assessment fees are the primary driver. The others are royalties from clinic data contribution.

Who are Life Whisperer's main competitors?

Direct peers on record are Vitrolife (Vitrolife Group), Fairtility and ImVitro. Emerging players are AIVF and Univfy. Broad incumbents are Hamilton Thorne, CooperSurgical (CooperCompanies) and FUJIFILM Irvine Scientific. Genea Biomedx is listed as a regional player. Ovation Fertility is listed as an others.

Does Life Whisperer have an API?

No public API is recorded for Life Whisperer.

What industry is Life Whisperer in?

Life Whisperer's product category is AI-powered IVF / Fertility Software. Its primary akta.pro industry code is HLALAHAA, Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation), with a secondary code of HLALAHAK, Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling). Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireAstec acquires AI fertility product Life WhispererAstec acquired Life Whisperer, an AI-based non-invasive assessment tool for embryo and oocyte evaluation. The tool includes three algorithms to improve IVF pregnancy outcomes, and Astec will roll it out globally after offering it in Japan and Indonesia.ImpakterAI Is Set to Change Fertility Treatment ForeverAI technology is increasingly being integrated into fertility treatments in China and India to enhance embryo selection accuracy, monitor development, and address declining birth rates. Companies such as Bloom IVF group, Life Whisperer, and Presagen are actively deploying these AI-led matrices and robotic technologies to improve diagnostic precision and treatment outcomes.PR NewswireLife Whisperer Genetics AI launches in the USA: Revolutionizing Embryo Euploidy Assessment with Non-Invasive, Instant, and Affordable TechnologyPresagen's AI-based fertility product Life Whisperer Genetics has launched commercially in the United States, offering IVF clinics a non-invasive, instant, and low-cost method to assess embryo euploidy using a single image. The technology provides an alternative to the existing PGT-A approach, which requires costly invasive biopsies, and also assists with SART reporting and lab efficiency. The launch was announced at the ASRM 2023 conference in New Orleans, where the company noted the US as a pivotal market and reported the product is already available in 47 countries including Canada, Europe, UK, SE Asia, Japan, India, and Australia.PR NewswireLife Whisperer launches its third global IVF clinic collaboration at ESHRE to apply Artificial Intelligence to OocytesLife Whisperer, the fertility arm of AI healthcare company Presagen, launched its third global IVF clinic collaboration at the 37th ESHRE Annual Meeting to apply AI to oocyte (egg) assessment, making it their third IVF product. Their existing products, Life Whisperer Viability and Genetics, evaluate embryo quality and perform 25% better than embryologist manual assessment while reducing time to pregnancy by 15%, with CE-Mark authorization covering two-thirds of the global IVF market. The company is inviting clinics of any size to contribute to the oocyte project in exchange for royalties on product sales, with presentations featuring partners including Ovation Fertility USA, IVF Life Europe, and Astra Fertility Canada.PR NewswireArtificial Intelligence helps IVF patients avoid invasive embryo genetic testingLife Whisperer, the fertility arm of AI healthcare company Presagen, has developed Life Whisperer Genetics, an AI product that non-invasively assesses embryo genetic health using camera images, eliminating the need for invasive PGT-A biopsy procedures. In a US study simulating 91,500 patient cohorts, the AI correctly ranked top genetically normal embryos in 82% of cases, with 96% having at least one genetically normal embryo in the top two rankings. The product is expected to launch in Europe, Australia, Canada, India, and Southeast Asia in May, while FDA approval is being pursued in the USA.PR NewswirePresagen and Life Whisperer Announce Call-out for a Global IVF Clinic Collaboration at CES 2020Life Whisperer, the fertility arm of AI healthcare company Presagen, announced at CES 2020 in Las Vegas a global call-out for IVF clinics to contribute data to develop a non-invasive AI-based genetic assessment product for embryo pre-screening. Research presented at the ASRM conference showed the AI technology can detect genetic abnormalities like Down Syndrome from embryo images alone, performing 25% better than experienced embryologists in a study of 1,600 embryo images. With 15 clinics across the US and Australia already committed, Life Whisperer aims to build a large, globally diverse dataset to underpin commercialization of the product, which offers a safer and lower-cost alternative to invasive PGT-A procedures.